Intriguingly, patients with liver metastasis showed significantly less CD8+ T cell infiltration into the tumor compared with those without liver metastasis32, suggesting VEGF-mediated T cell exclusion within tumors and explaining the attenuated response to anti-PD-1 therapy in VEGF-high tumors. The gene discussed is VEGFA; the disease is neoplasm.